Senior Director, US Tax & M&A Strategy

Jazz Pharmaceuticals; Palo Alto (CA); On-site; USD 226,000 - 340,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

401k retirement savings

Flexible vacation

Job summary

Jazz Pharmaceuticals, a global biopharma company, is seeking a Senior Director to oversee US corporate income taxes, ASC 740 accounting, tax provisioning, and compliance. The role includes leading tax planning, audit support, and cross-border transactions with internal teams and external advisors.

The candidate will manage external tax advisors, enhance governance, and ensure SOX compliance within the tax function while collaborating on M&A and international tax initiatives with Finance, Legal,

Qualifications

• Extensive US federal, state, and international tax experience including ASC 740 accounting and compliance.
• Experience leading cross-functional tax projects, including M&A transactions.
• Knowledge of US tax code provisions and audit support.

Responsibilities

• Oversee quarterly and annual ASC 740 tax provisioning and compliance.
• Lead tax planning and structuring on acquisitions and integrations.
• Manage external advisors and tax projects, ensuring on-time deliverables and budgets.
• Liaise with tax authorities and maintain SOX framework within tax function.
• Provide technical leadership on complex US and international tax matters.

Skills

US tax experience

ASC 740

US federal tax

US state tax

US international tax

Tax provisioning

Cross-functional leadership

M&A tax

Self-motivation

Education

CPA and/or Masters - Taxation

Job description

Jazz Pharmaceuticals, a global biopharma company, is seeking a Senior Director to oversee US corporate income taxes, ASC 740 accounting, tax provisioning, and compliance. The role includes leading tax planning, audit support, and cross-border transactions with internal teams and external advisors.

The candidate will manage external tax advisors, enhance governance, and ensure SOX compliance within the tax function while collaborating on M&A and international tax initiatives with Finance, Legal,